• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Healthcare·MLLAB.PA
Share

Media Lab S.p.A. Stocks

€ 2.48Last Updated 21.09.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

€ 6.75M

€ 2.48
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Media Lab S.p.A. specializes in providing information technology solutions tailored for the dental industry. The company's offerings include Implant 3D, a sophisticated software designed for planning dental implants and generating surgical guides, which empowers users to conduct three-dimensional implant simulations directly on their personal computers. Furthermore, Media Lab S.p.A. supplies various instruments and accessories crucial for implantology and guided surgical techniques, as well as delivering professional training programs. Established in 1994, the company's headquarters are situated in Milan, Italy.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.09.2026 03:58

The Dow ended its three-week losing streak. Meta and Apple hit record highs.

26.09.2026 03:18

BofA downgraded Nike's rating. Wall Street's pessimism toward the brand is at a 25-year high.

26.09.2026 01:44

The Fed Is Underestimating Record-High Diesel Prices in the U.S.: They Will Drive Up Inflation — Apollo

26.09.2026 00:28

Bill Gates: AI is a technology powerful enough to cause “a billion deaths”

25.09.2026 23:25

The Fed Wants to Raise the Regulatory Threshold for Banks — Reuters. Who Stands to Gain from This?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026